Germany's Merck to buy Bio-Techne for $11.3 billion

🇩🇪 CNBC (DE) — 2026-06-25

German life science and healthcare firm Merck KGaA has agreed to acquire US-based biotech company Bio-Techne for $11.3 billion. This significant deal aims to strengthen Merck's position in the biotechnology and healthcare sectors.

Merck KGaA has agreed to acquire biotech firm Bio-Techne for $11.3 billion, the ⁠German ‌science and healthcare ⁠firm said in a statement on Thursday.

Markets Deals Health Merck KGaA Bio-Techne acquisition biotech healthcare Germany United States

Read original source →

Trump deal gives Iran 100s of billions more than Obama’s nuclear pact he slammed, in return for far less
Small Wars Journal — 2026-06-25
EU releases €3 billion loan for Ukraine’s recovery
South China Morning Post — 2026-06-25
Dollar Consolidates, Oil Slips Lower, Equities Helped By Micron Earnings
Seeking Alpha — 2026-06-25
Brazil’s Police Launches Second Phase of Probe Into Americanas
Bloomberg — 2026-06-25
Anthropic hires Orange’s AI chief amid Europe push
Investing.com — 2026-06-25
Crypto token plunges 70%, taking market cap below $1 billion
MarketWatch — 2026-06-25

Germany's Merck to buy Bio-Techne for $11.3 billion

AI Summary

Related Articles

Trump deal gives Iran 100s of billions more than Obama’s nuclear pact he slammed, in return for far less

EU releases €3 billion loan for Ukraine’s recovery

Dollar Consolidates, Oil Slips Lower, Equities Helped By Micron Earnings

Brazil’s Police Launches Second Phase of Probe Into Americanas

Anthropic hires Orange’s AI chief amid Europe push

Crypto token plunges 70%, taking market cap below $1 billion